Wealthstreet Investment Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
RJA
MCM
SPIA
Wealthstreet Investment Advisors's IHE Position: Q3 2021 in Review
Wealthstreet Investment Advisors sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2021, closing a stake of 150 shares — an estimated $9K sold.
Wealthstreet Investment Advisors first reported a position in IHE in Q4 2017 and held it in 15 quarters. The position peaked at $1.14M in Q3 2020. 110 funds tracked by Wall St. Rank hold IHE as of Q3 2021.
- Wealthstreet Investment Advisors reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2021 after selling out during the quarter.
- Wealthstreet Investment Advisors sold 150 iShares US Pharmaceuticals ETF shares in Q3 2021, an estimated $9K.
- Wealthstreet Investment Advisors first reported a position in iShares US Pharmaceuticals ETF in Q4 2017 and held it in 15 quarters.
- Wealthstreet Investment Advisors's iShares US Pharmaceuticals ETF position peaked at $1.14M in Q3 2020.
- 110 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2021.
Based on Wealthstreet Investment Advisors's 13F filing for Q3 2021, filed 2 Nov 2021.